Key terms
About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest AMGN news
Today
8:30am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Today
8:01am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: AbSci (ABSI) and Amgen (AMGN)
May 17
8:11am ET
Analysts Offer Insights on Healthcare Companies: CareDx (CDNA), Amgen (AMGN) and Orasure Technologies (OSUR)
May 17
7:40am ET
Analysts’ Top Healthcare Picks: Amgen (AMGN), Aytu BioScience (AYTU)
May 17
7:10am ET
Analysts Are Bullish on These Healthcare Stocks: Amgen (AMGN), Eli Lilly & Co (LLY)
May 17
6:13am ET
U.S. FDA Approves Amgen’s (NASDAQ:AMGN) Imdelltra
May 16
6:56pm ET
Balancing Early Approval and Market Challenges: Amgen’s Imdelltra Receives a Hold Rating from Carter Gould
May 16
6:48pm ET
Amgen says FDA approves Imdelltra
May 16
3:33pm ET
FDA grants accelerated approval for Amgen’s tarlatamab-dlle
May 09
11:48pm ET
Dow Jones (DJIA) Dominates in May: Here’s Why the Trend Could Continue
May 09
7:00am ET
Amgen price target raised to $235 from $223 at Mizuho
May 09
6:57am ET
Wedbush upgrades CytomX to Outperform on ‘encouraging’ CX-904 Phase 1a data
May 08
6:32am ET
Drugmakers work to make treatments to maintain weight loss, WSJ reports
May 08
12:10am ET
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), Amgen (AMGN) and Elevation Oncology (ELEV)
May 06
3:45pm ET
Fly Insider: Theravance Bio, Amgen among week’s notable insider trades
May 06
1:05am ET
Amgen’s Strong Q1 Performance and Promising Pipeline Justify Buy Rating
May 05
7:42pm ET
CytomX Therapeutics upgraded to Buy from Hold at Jefferies
May 04
12:25am ET
BMO Capital Reaffirms Their Buy Rating on Amgen (AMGN)
May 03
11:34am ET
Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Kura Oncology (KURA) and Amgen (AMGN)
May 03
11:13am ET
Amgen price target raised to $325 from $315 at BofA
May 03
11:09am ET
Amgen price target lowered to $328 from $332 at RBC Capital
May 03
9:55am ET
Early notable gainers among liquid option names on May 3rd
May 03
9:32am ET
Amgen upgraded, Peloton downgraded: Wall Street’s top analyst calls
May 03
9:13am ET
Amgen price target raised to $310 from $271 at Morgan Stanley
May 03
8:08am ET
Oppenheimer Remains a Buy on Amgen (AMGN)
May 03
8:06am ET
Amgen (AMGN) Receives a Buy from Piper Sandler
May 03
7:46am ET
Amgen up due to positive obesity data, says Jefferies
May 03
7:45am ET
AMGN Earnings: Amgen Surges After Raised Forecast, Weight Loss Drug Update
May 03
7:39am ET
Amgen price target raised to $307 from $284 at UBS
May 03
7:10am ET
William Blair upgrades Amgen on confidence in upcoming obesity data
May 03
7:07am ET
Analysts Offer Insights on Healthcare Companies: Day One Biopharmaceuticals (DAWN), Amgen (AMGN) and Omnicell (OMCL)
No recent press releases are available for AMGN
AMGN Financials
Key terms
Ad Feedback
AMGN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
AMGN Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
